跳至主要内容
临床试验/EUCTR2014-002667-15-AT
EUCTR2014-002667-15-AT进行中(未招募)不适用

Effect of Dual Bronchodilatation on Broncholysis Testing in COPD Patients

Medizinische Universität Innsbruck, Innere Medizin VI0 个研究点开始时间: 2014年8月7日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1) Informed Consent Form signed by a patient;
  • 2) Male and female adults = 40 years old;
  • 3) Patients diagnosed with COPD accoridng to GOLD criteria with:a post-bronchodilations FEV1 < 80% of predicted FEV1 and a post-bronchodilations FEV1/FVC <70%;
  • 4) Patients with stable medication for at least 4 weeks;
  • 5) Active or former smoking status with > 10 YP;
  • 6) No known allergies
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1) A significant disease other than COPD (defined in protocol) diagnosed;
  • 2) Pregnant of lactating women;
  • 3) Never-smokers;
  • 4) Hypersensitivity to IMP;
  • 5) Known bronchial asthma;
  • 6) Intake of prohibited medication (Daxas, theophylline, oral betamimetics);
  • 7) Patients already participating in another clinical trial;
  • 8) no informed consent form sign

研究者

发起方
Medizinische Universität Innsbruck, Innere Medizin VI

相似试验